Long-term Characterization of GORE® TAG® Conformable Thoracic Stent Graft With ACTIVE CONTROL System Performance (NCT06658730)
🩺 Plain-English Summary (8th-Grade Level)
An observational, prospective multi-regional post-market registry collecting mid- and long-term data to assess outcomes through ten years of follow-up for subjects treated with GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System as a part of routine clinical practice. This post-market registry for the GORE® TAG® Conformable Thoracic Stent Graft with ACTIVE CONTROL System (CTAG w/AC) is intended to demonstrate that thoracic endovascular aortic repair (TEVAR) for lesions of the descending thoracic aorta continues to be a suitable treatment option for appropriately selected patients.
Who can join: Review the eligibility criteria below.
Location: University of Arizona — Tucson, Arizona
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (37 Sites)
Showing the first 25 of 37 sites.
- University of Arizona — Tucson, Arizona
- University of Southern California — Los Angeles, California
- Cedars-Sinai Medical Center — Los Angeles, California
- Leland Stanford Junior University — Stanford, California
- MedStar Health, MedStar Washington Hospital Center — Washington D.C., District of Columbia
- University of Florida - Gainesville — Gainesville, Florida
- University of South Florida — Tampa, Florida
- Augusta University — Augusta, Georgia
- Indiana University School of Medicine — Indianapolis, Indiana
- University of Maryland - Baltimore — Baltimore, Maryland
- Beth Israel Deaconess Medical Center — Boston, Massachusetts
- The Hitchcock Foundation at Dartmouth Hitchcock Medical Center — Lebanon, New Hampshire
- Hackensack University Medical Center — Hackensack, New Jersey
- University of North Carolina at Chapel Hill — Chapel Hill, North Carolina
- Duke University — Durham, North Carolina
- University Hospitals - Cleveland Medical Center — Cleveland, Ohio
- University of Pennsylvania — Philadelphia, Pennsylvania
- Thomas Jefferson University — Philadelphia, Pennsylvania
- Baylor Research Institute — Dallas, Texas
- Columbia Medical Center of Plano — Plano, Texas
- Intermountain Medical Center — Murray, Utah
- Sentara Medical Group, Sentara Norfolk General Hospital — Norfolk, Virginia
- University of Washington — Seattle, Washington
- University of Wisconsin — Madison, Wisconsin
- Rigshospitalet — Copenhagen,
📞 Contact the Study Coordinator
Phone: (928) 864-3987
Email: ahoedt@wlgore.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
Explore by condition: All Vascular Disease clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.